Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Clene, Maintains $15 Price Target

HC Wainwright & Co. Reiterates Buy on Clene, Maintains $15 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $15 price target.

byBenzinga Newsdesk

March 13, 2023

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $15 price target.

Keybanc Maintains Overweight on PulteGroup, Raises Price Target to $66

By Benzinga Newsdesk

February 3, 6:44 AM

Keybanc analyst Kenneth Zener maintains PulteGroup (NYSE:PHM) with a Overweight and raises the price target from $51 to $66.

PHM

News

Actelis Ramps Up Rollout of IoT Networks for Major Airports Worldwide in Seven Countries Spanning America, Europe, and Asia; Co. Says Received $312K To-Date In Orders

By Michael Horton

August 29, 4:31 PM

Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company") a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, announced today

ASNS

News

The New England Journal of Medicine Publishes Second Manuscript Reporting Positive Phase 2 Results for Biogen’s Litifilimab (BIIB059) in Lupus

By Michael Horton

September 7, 5:46 PM

Biogen Inc. (NASDAQ:BIIB) today announced that The New England Journal of Medicine (NEJM) has published a second manuscript detailing positive results from the company's two-part Phase 2

BIIB